Nasdaq · Healthcare

AVITA Medical, Inc. (RCEL)

As-reported financials and recent SEC filings for AVITA Medical, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$71.6M

Net income

$-48.6M

Net margin

-67.8%

Diluted EPS

$-1.74

ROE

291.8%

P/E (TTM)

—

Market cap

—

Debt / equity

0.0×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$71.6M	$64.3M	$50.1M	$34.4M	$29.2M
Gross profit	$58.8M	$55.2M	$42.4M	$28.4M	$23.3M
Operating income	$-42.5M	$-56.6M	$-42.7M	$-27.5M	$-26.5M
Net income	$-48.6M	$-61.8M	$-35.4M	$-26.7M	$-26.6M
Diluted EPS	$-1.74	$-2.39	$-1.40	$1.07	$1.17

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-12

42026-06-10

42026-06-09

8-K2026-06-08

424B52026-06-08

42026-06-05

42026-06-04

8-K2026-06-04

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on RCEL

Search AVITA Medical, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.